News and Announcements
Richard Hopkins appointed Phylogica CEO
- Published July 19, 2013 10:48AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
PERTH, AUSTRALIA: 19 July 2013: Leading Australian peptide drug discovery company Phylogica Limited (ASX:PYC, XETRA:PH7) has appointed Dr Richard Hopkins as the company’s new Chief Executive Officer as part of a broad company strategic review. He will be appointed to the Board effective immediately.
Dr Hopkins has been with Phylogica since 2006, where he has served in variety of positions, most recently as Chief Scientific Officer (CSO). Dr Hopkins has worked with the phylomer platform for over 12 years and is a founding shareholder in Phylogica. Prior to that, he held senior research roles including with the Telethon Institute for Child Health Research, Department of Medicine at the University of Western Australia and Murdoch University.
To read the full ASX announcement, please download the document below.